DJ Abbott Laboratories Stock Outperforms Competitors On Strong Trading Day
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Abbott Laboratories $(ABT)$ rose 2.13% to $107.96 Thursday, on what proved to be an all-around rough trading session for the stock market, with the S&P 500 Index falling 0.18% to 7,709.96 and Dow Jones Industrial Average falling 0.85% to 53,885.10.
This was the stock's second consecutive day of gains.
Abbott Laboratories closed 21.48% short of its 52-week high of $137.49, which the company reached on September 22nd.
The stock outperformed some of its competitors Thursday, as Johnson & Johnson $(JNJ)$ fell 0.24% to $256.98, Pfizer Inc. $(PFE)$ rose 1.51% to $26.20, and Merck & Co. Inc. $(MRK)$ rose 0.03% to $128.37.
Trading volume (8.9 M) remained 4.2 million below its 50-day average volume of 13.0 M.
Data source: Dow Jones Market Data, FactSet. Data compiled August 6, 2026.